The latest report on Immunosuppressant Drugs Market by Infinium Global Research gives complete coverage of the immunosuppressant drugs market by rug type (calcineurin inhibitors, center for biotechnology, antiproliferative agents), route of administration (intravenous, oral), application (organ transplant, autoimmune disease), end-user (organ transplant centers) in terms of key trends, market size, forecast and CAGR growth over the period of 2019 to 2025. In addition, the study covers deep dive into key product and applications trends in the regional markets of immunosuppressant drugs such as North America, Europe, Asia-Pacific and Latin America over the short run and long run. The global immunosuppressant drugs market is projected to grow at a CAGR of 4.9% over the forecast period of 2019-2025.

Get Sample Report Copy for Market Insights @

Immunosuppressant drugs are used in post organ transplants. It has applications in the treatment of different autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and psoriasis. After an organ transplant, the immunity of patients has to be subdued to allow the patient’s body to accept the newly planted organ. These are anti-rejection drugs that make the body less likely to reject a transplanted organ such as the heart, liver, or kidney.

Rise in the Number of Organ Transplantation Procedures Drives the Growth of the Immunosuppressant Drugs Market

The rise in the number of organ transplantation procedures drives the growth of the immunosuppressant drugs market. As per the Global Observatory on Donation and Transplantation report, there was 139024 organ transplantation occurred in 2017. There is a significant increase in organ transplantation procedures in recent years. The rising number of organ transplantation for kidneys, lungs, liver, pancreas, and other organs led to increasing demand for immunosuppressant drugs. Kidney is the most transplanted organ globally. In 2017, 36% of the total number of transplantations was for the kidney. Immunosuppressant drugs play a vital role in the success of organ transplant procedures.

Further, the growing prevalence of autoimmune disease owing to changing lifestyles stimulates the expansion of the market. The changes in dietary habits lead to stress, insufficient sleep, unhealthy eating habits, smoking, and different environmental factors that promote the rise in autoimmune diseases such as lupus, celiac disease, and others. The increasing advancements in tissue engineering and organ transplant techniques promote the growth of the immunosuppressant drugs market.

Additionally, increasing prevalence of chronic ailments and a rise in demand for organ replacement boost the expansion of the immunosuppressant drugs market. On the flip side, the high cost of the drugs restraints the growth of the immunosuppressant drugs market. Moreover, the adoption of advanced medical treatments and the rising use of tissue engineering create several opportunities for the growth of the immunosuppressant drugs market.

North America is Expected to Hold the Largest Share in the Global Immunosuppressant Drugs Market

Geographically, the global immunosuppressant drugs market is divided into North America, Asia-Pacific, Europe, and the Rest of the World. North America is expected to hold the largest share in the global immunosuppressant drugs market. The growing prevalence of autoimmune diseases and the increasing number of organ transplants in North America drive the growth of the immunosuppressant drugs market in the region. A study estimated that in the United States around 24 million people are having an autoimmune disease. In addition, as of September 2019, the number of organ transplant candidates in the United States is 112947. Europe is expected to grow in the global immunosuppressant drugs market with a healthy CAGR over the forecast period.

The rising number of transplants in Europe contributes to the expansion of the immunosuppressant drugs market in Europe. Asia-Pacific region has lucrative growth opportunities in the global immunosuppressant drugs market owing to the well-established healthcare industry and growing medical tourism in the region.

Table of Content

Chapter – 1      Preface

Chapter – 2      Executive Summary

Chapter – 3      Global Immunosuppressant Drugs Market Overview

Chapter – 4      Immunosuppressant Drugs Market Macro Indicator Analysis

Chapter – 5      Global Immunosuppressant Drugs Market by Drug Type

  • Calcineurin Inhibitors
  • Center for Biotechnology
  • Antiproliferative Agents
  • IMDH Inhibitors

Chapter – 6      Global Immunosuppressant Drugs Market by Route of Administration

  • Intravenous
  • Oral
  • Other Routes

Chapter – 7      Global Immunosuppressant Drugs Market by Application

  • Organ Transplant
  • Autoimmune Disease
  • Kidney Transplant
  • Liver Transplant
  • Heart Transplant

Chapter – 8      Global Immunosuppressant Drugs Market by End-user

  • Organ Transplant Centers
  • Hospitals and Clinics
  • Other End-users

Chapter – 9      Global Immunosuppressant Drugs Market by Region 2019-2025

  • North America
  • Europe
  • Asia-Pacific
  • RoW

Chapter – 10    Company Profiles and Competitive Landscape

  • Genzyme Corp.
  • Astellas Pharma Inc.
  • Accord Healthcare Ltd.
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals, Inc.
  • Hoffmann-La Roche AG
  • Mylan Laboratories Ltd.
  • Pfizer Inc.
  • Novartis International AG

Chapter – 11    Appendix

  • Primary Research Findings and Questionnaire

Browse Detailed TOC and Description of this Exclusive [email protected]

About Infinium Global Research

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide the knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations and environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.


Leave a comment

Your email address will not be published. Required fields are marked *